Cellares rebukes Bristol Myers’ criticism of its cell therapy technology
Cell therapy manufacturing startup Cellares is defending itself against Bristol Myers Squibb after the drugmaker pulled out of…
Lundbeck continues neuroscience evolution as CEO keeps company ‘punching above its weight’
Almost three years into his tenure as Lundbeck’s CEO, Charl van Zyl is confident the company can prove…
Lilly’s long-acting insulin wins NICE blessing ahead of potential UK approval
For patients living with Type 2 diabetes in the United Kingdom, a more convenient treatment option may be…
EU regulators offer post-mortem of Tavneos withdrawal decision
With the European Union formally reversing its marketing authorization for the rare disease med Tavneos last week, regulators…
FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years – Endpoints News
FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years Endpoints News FDA…
Colorado wins FDA approval to import cheaper drugs from Canada
Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to…
Generic semaglutide to hit Canadian pharmacies this week at a fraction of the cost of Ozempic – Toronto Star
Generic semaglutide to hit Canadian pharmacies this week at a fraction of the cost of Ozempic Toronto Star Generic…
What Britain wants from King Charles’ trip to Trumpland – POLITICO
The monarch also appears likely to emphasize Britain’s commitment to the two nations’ defense ties — which include…
Tips to help choose over-the-counter medications safely and wisely – The Irish Times
Over-the-counter (OTC) medications help people cure some simple diseases easily and without seeing a doctor. Some OTC drugs…
Why Orbán’s man in Brussels is here to stay — for now – POLITICO
“He is one of the commissioners who actually reads up on the stuff,” said a European Parliament official,…